Baystreet Staff - Thursday, March 30, 2017 Anthera Pharmaceuticals (ANTH) Gains on Positive Test Results Anthera Pharmaceuticals Inc (NASDAQ: ANTH) rose 3% to 44 cents after the company reported positive results from the Extension Period of SOLUTION study of Sollpura. Share volume was 4.3 million, nearly double its all-day average